Table 2. The association between CEP55 expression and the demographic and clinicopathological parameters of patients with primary LUSC in TCGA.
Parameters | CEP55 expression | CEP55 expression | χ2 | p Value | |
---|---|---|---|---|---|
High (N = 137) | Low (N = 357) | ||||
Age (Mean ± SD) | 64.9403 ± 8.269667 | 68.09577 ± 8.518631 | <0.001 | ||
Gender | Female | 23 | 105 | 8.218 | 0.004 |
Male | 114 | 252 | |||
Smoking History | 1/2 | 22 | 49 | 0.353 | 0.552 |
3/4/5 | 91 | 240 | |||
Discrepancy+null | 24 | 68 | |||
Clinical Stage | I/II | 109 | 291 | 0.277 | 0.599 |
III/IV | 27 | 63 | |||
Discrepancy+null | 1 | 3 | |||
Recurrence status | No | 77 | 209 | 0.000222 | 0.988 |
Yes | 27 | 73 | |||
Null | 33 | 75 | |||
Living Status | Living | 84 | 198 | 1.384 | 0.239 |
Dead | 53 | 159 |